THER
Theralink Technologies, Inc.
OTCHealthcareBiotechnologyUS
Rating:C-
Company Profile
CEO
Michael I. Ruxin
IPO Date
2010-04-01
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Country
US
Theralink Technologies, Inc.
CEO
Michael I. Ruxin
IPO Date
2010-04-01
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Country
US
| 44,314,286 |
| $0.00 |
| 2 Feb 2024 | Busch Jeffrey | director | A-Award | Acquired | 15,714,286 | $0.00 |
| 2 Feb 2024 | Busch Jeffrey | director | A-Award | Acquired | 0 | $0.00 |
| 2 Feb 2024 | Busch Jeffrey | director | J-Other | Acquired | 0 | $0.00 |
| 26 Jan 2024 | Holley Danica | director | J-Other | Acquired | 17,029,905 | $0.00 |
| 26 Jan 2024 | Holley Danica | director | J-Other | Acquired | 2,100,840 | $0.00 |
| 26 Jan 2024 | Holley Danica | director | J-Other | Acquired | 0 | $0.00 |
| 26 Jan 2024 | Holley Danica | director | J-Other | Disposed | 0 | $0.00 |
| 21 Sept 2022 | Chilcott, III Thomas E. | Chief Financial Officer | A-Award | Acquired | 94,545,096 | $0.00 |